Podcast Episodes
Back to Search
Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients
Season 25 Episode 117
Dr Natalie S Callander and Dr Sagar Lonial provide clinical perspectives on the treatment and disease-management course for patients with relapsed/refractory multiple myeloma.
CME information and sel…
Published on 4 hours ago
Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
Season 25 Episode 116
Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers.
CME information and select publications here.
Published on 22 hours ago
Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches
Season 25 Episode 115
Dr Sarah Sammons from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses cases and reviews the current management of brain metastases in patients with HER2-positive breast cancer.
CME i…
Published on 3 days, 22 hours ago
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
Season 25 Episode 114
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigatio…
Published on 6 days, 22 hours ago
Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
Season 25 Episode 113
Dr Shannon Westin from the University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for ovarian and endometrial cancer.
CME infor…
Published on 1 week, 1 day ago
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Season 25 Episode 112
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. …
Published on 1 week, 6 days ago
Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma
Season 25 Episode 111
For this patient-focused webinar, medical oncologist Dr Neil Love is joined by Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Sagar Lonial from the Wi…
Published on 2 weeks, 1 day ago
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
Season 25 Episode 110
Dr Jorge Cortes from Georgia Cancer Center at Augusta University discusses patient cases and summarizes current treatment approaches for FLT3- and IDH1/2-mutant acute myeloid leukemia.
CME informatio…
Published on 2 weeks, 3 days ago
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Season 25 Episode 109
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investi…
Published on 3 weeks, 1 day ago
Multiple Myeloma — Optimizing the Selection of First-Line Therapy
Season 25 Episode 108
Prof Xavier Leleu and Dr Peter Voorhees review relevant clinical data regarding first-line treatment decisions for patients with multiple myeloma.
CME information and select publications here.
Published on 3 weeks, 1 day ago